Post hoc analysis of a phase IIb RTS,S malaria vaccine trial in 735 children aged 1-4: high IgG to the NANP2 and J1 CSP epitopes was associated with lower clinical malaria risk vs low responses (aHR 0.838 and 0.718).
Secondary analysisn = 735
Hysa et al. Antibody fine specificity correlates with protection from malaria for the RTS,S vaccine in young African children: A post hoc analysis of a phase IIb randomised controlled trial